ArticleMaterials (Basel, Switzerland)2026
Temperature-Adaptive Carrier Regulation and Enhanced Thermoelectric Performance in n-Type PbTe via Deep-Shallow Co-Doping.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Optimizing the carrier concentration across the entire operating temperature range is crucial for maximizing the power factor in n-type PbTe. However, conventional shallow donors produce a nearly temperature-invariant electron concentration, leading to an increasingly large deviation from the optimal carrier concentration at elevated temperatures. Herein, we implement a dynamic deep-shallow co-doping strategy by combining iodine (a shallow donor) with gallium (a deep-level donor) in PbTe. The Ga-related deep impurity states thermally ionize at elevated temperatures, providing additional electrons and driving the Hall carrier concentration above ~563 K toward its temperature-dependent optimum. Concurrently, our optimized synthesis preserves a high carrier mobility, which synergistically sustains a remarkable peak power factor of 30 μW·cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.